There is no authoritative data on the time for barrett’s esophagus to develop into esophageal cancer, but it is generally accepted that the risk of deterioration is higher after the occurrence of intestinal epithelial hyperplasia, and surgery is required.
Barrett’s esophagus is mainly characterized by microscopic esophageal epithelial hyperplasia, and the risk of cancer is higher if accompanied by intestinal epithelial hyperplasia. The cancer rate of barrett’s esophagus is about 0.61%, but it should be noted that 80% of esophageal adenocarcinomas are closely related to barrett’s esophagus.
However, it should be noted that 80% of esophageal adenocarcinomas are closely related to barrett’s esophagus. Therefore, it is recommended to treat barrett’s esophagus in a timely manner when it is found to be a high-risk type.
Treatment of barrett’s esophagus is based on endoscopic treatment such as endoscopic mucosal dissection and endoscopic mucosal resection. For those who are found to have concomitant intestinal epithelial hyperplasia on postoperative pathologic examination, endoscopic review is recommended every 3 months-1 year or so.
If barrett’s esophagus is found, it is recommended to go to the hospital in time and follow the doctor’s instructions for treatment.